OTTAWA, April 14, 2016 /CNW/ - The Canadian Medical Cannabis Industry Association (CMCIA) is pleased to announce that its membership has elected a new Board of Directors for 2016-2017. Each of the new Directors is a senior executive at a Licensed Producer of medical cannabis under Health Canada's Marihuana for Medical Purposes Regulations (MMPR). The Board election took place during the Association's Annual General Meeting in Toronto, on April 6, 2016.
Neil Closner, CEO of MedReleaf was elected as the new Chair of the Association, succeeding Marc Wayne, co-founder and President of Bedrocan Canada, and a Managing Director of Canopy Growth Corporation. Mr. Wayne, CMCIA's founding Chair, will now serve in an ex officio role as Past Chair.
Re-elected for one year terms along with Mr. Closner were:
- Trevor Fencott, co-founder and Chief Legal Officer at Mettrum Health
- Mark Zekulin, President of Tweed Inc. and a Managing Director of Canopy Growth Corporation
Newly-elected for two year terms were:
- Cam Battley, Senior Vice President, Communications and Medical Affairs at Aurora Cannabis
- Avtar Dhillon, M.D, Executive Chairman of Emerald Health Botanicals
- John Fowler, President and CEO of Supreme Pharmaceuticals
- Vic Neufeld, CEO of Aphria
"On behalf of CMCIA's membership, I am very pleased to welcome our new and returning Directors, who will provide governance and guidance for the Association during a particularly important period," said Colette Rivet, Executive Director of CMCIA. "This is a strong Board, featuring members with extensive business leadership experience and a diversity of skills. They will serve the Association well as we participate in public and policy discussions regarding the expansion of Canada's medical cannabis system, as well as the federal government's plans to create a legal, regulated adult consumer market for cannabis."
The Canadian Medical Cannabis Industry Association (CMCIA) is Canada's leading member-driven association for Licensed Producers (LPs) of medical cannabis. The Association represents the majority of producers currently licensed under Health Canada's Marijuana for Medical Purposes Regulations (MMPR).
CMCIA's mission is to promote national standards and best practices by supporting the development, growth and integrity of the medical cannabis industry. The Association acts as the national voice for Canada's LPs, and serves as a credible and trusted resource on issues related to the medical cannabis industry.
The Association shares a philosophy of patient-centric care and improved public health, and is committed to product safety and quality, secure and reliable access for registered patients, and the promotion of the safe and effective use of cannabis for medical purposes. www.cmcia.ca
SOURCE Canadian Medical Cannabis Industry Association
For further information: Cam Battley, Chair, Advocacy Committee, CMCIA, firstname.lastname@example.org, 905.864.5525